Records containing: Herpes Zoster
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-03-01A Randomized, Observer-Blinded, Active-Controlled, Phase I Study to Evaluate the Safety and Immunogenicity of the Recombinant Zoster Vaccine (CHO Cell) in Healthy Adults Aged 40 Years and Older
-
CLINICAL_TRIALS study record update · 2024-01-18A Phase 3b, Open-label, Multi-country, Multi-centre, Long-term Follow-up Study of ZOSTER-049 (Follow-up of ZOSTER-006/022 Studies) to Assess the Prophylactic Efficacy, Safety and Persistence of Immune Response of a Herpes Zoster Subunit Vaccine and Assessment of Persistence of Immune Response and Safety of 1 or 2 Additional Doses Administered in ZOSTER-049 in 2 Subgroups of Older Adults
-
CLINICAL_TRIALS study record update · 2024-01-17Evaluation of Herpes Zoster Characteristics and Costs in Cancer Population.
-
CLINICAL_TRIALS study record update · 2023-12-29A Multicenter, Randomized, Active-controlled, Dose-finding Phase II Clinical Study Evaluating the Safety and Efficacy of Peginterferon α1b for Injection in Patients With Herpes Zoster
-
CLINICAL_TRIALS study record update · 2023-12-27A Safety and Immunogenicity Study of a Zoster Vaccine in Healthy Adults >= 40 Years
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-12-20Long-term Immunogenicity Study of Herpes Zoster Subunit Vaccine (GSK1437173A) and Immunogenicity and Safety Assessment of Revaccination With Two Additional Doses in Adults With Renal Transplant From Study ZOSTER-041
-
CLINICAL_TRIALS study record update · 2023-11-22Training the Innate Immune System Against SARS-COV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents: A Randomized, Doubled-Blinded, Comparative Group Observational Study
-
CLINICAL_TRIALS study record update · 2023-11-13A Phase III, Randomized, Open-label, Controlled, Multicenter Study to Evaluate the Immune Response and Safety of Both Herpes Zoster Subunit Vaccine in Healthy Adults Aged 50 Years and Older AND the Influenza Virus Vaccine in Healthy Adults Aged 18 Years and Older When Administered Sequentially or Coadministered With mRNA-1273 Booster Vaccination
-
CLINICAL_TRIALS study record update · 2023-10-27Nationwide Retrospective Observational Study of Herpes Zoster Associated Hospital Admissions in Italy
-
CLINICAL_TRIALS study record update · 2023-10-18A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial to Evaluate the Protective Efficacy, Safety, and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Subjects Aged 40 Years and Older
-
CLINICAL_TRIALS study record update · 2023-06-29Exploratory Study Into Age-related Immunological Differences Related to Immunogenicity in Influenza Vaccination and Herpes Zoster Vaccination
-
CLINICAL_TRIALS study record update · 2023-04-10A Multicenter, Randomized, Double-blind, Controlled, Non-inferiority Phase III Clinical Trial of Recombinant Human Interferon Alpha-2b Gel (ZK-A03) in Treatment of Herpes Zoster Before and After the Alteration of the Active Ingredient Manufacturer
-
CLINICAL_TRIALS study record update · 2023-03-27A Randomized, Double-blind, Placebo-controlled Phase I Clinical Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine (LZ901) in Subjects Aged 50 to 70 Years Inclusive
-
CLINICAL_TRIALS study record update · 2023-03-22Treatment of Chronic Postherpetic Pain With Autologous Fat Grafting - A Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2023-02-08A Phase I, Randomized, Observer-blinded Study to Evaluate the Safety, Tolerability, and Immunogenicity of BV211 in Adult Volunteers
-
CLINICAL_TRIALS study record update · 2022-12-15The Epidemiology, Management, and the Associated Burden of Mental Health, Atopic and Autoimmune Conditions, and Common Infections in Alopecia Areata
-
CLINICAL_TRIALS study record update · 2022-12-06A Phase I,Randomized, Double-blind,Placebo Controlled,Dose Escalated, Single Adminstrated Clinical Trial of PEGIFNα1b in Chinese Healthy Adults
-
CLINICAL_TRIALS study record update · 2022-11-07A Phase 1 Randomized, Subject-Blinded, Active-Controlled, Dose Escalation, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers Between the Ages of 50 and 69 Years
-
CLINICAL_TRIALS study record update · 2022-10-26Efficacy and Safety of Recombinant Zoster Vaccine in Stable SLE Patients(Vtrial)
-
CLINICAL_TRIALS study record update · 2022-09-07The Safety and Clinical Utilities of the Fluoroscopy-guided Cervical Epidural Approach Using the Contralateral Oblique View: a Prospective Observational Study
-
CLINICAL_TRIALS study record update · 2022-07-18The Efficacy and Safety of Intradermal Acupuncture for Acute Herpes Zoster: Study Protocol for a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2022-07-14Post-Licensure Observational Study of the Long-term Effectiveness of ZOSTAVAX™
-
CLINICAL_TRIALS study record update · 2022-02-04Supporting Health Care Professionals in Hospital and Primary Care to Promote Adequate HIV Risk and Indicator Condition Driven Testing in Routine Care.
-
CLINICAL_TRIALS study record update · 2021-12-08Evaluation of the Efficacy of Attenuated Zoster Vaccine, Live From Herpes Zoster in Adults Aged 40 Years or older---a Multicenter, Randomized, Double-blinded,Placebo-controlled Trial Phase III
-
CLINICAL_TRIALS study record update · 2021-06-28A Multi-centered, Randomized Study to Evaluate the Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection Compared to Intravenous Acyclovir in Patients With Herpes Zoster From China